CD103(+) cDC1 and endogenous CD8(+) T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function

While effective in specific settings, adoptive chimeric antigen receptor (CAR) T cell therapy for cancer requires further improvement and optimization. Our previous results show that CD40L-overexpressing CAR T cells mobilize endogenous immune effectors, resulting in improved antitumor immunity. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuhn, Nicholas F., Lopez, Andrea V., Li, Xinghuo, Cai, Winson, Daniyan, Anthony F., Brentjens, Renier J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710757/
https://www.ncbi.nlm.nih.gov/pubmed/33268774
http://dx.doi.org/10.1038/s41467-020-19833-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710757/
https://www.ncbi.nlm.nih.gov/pubmed/33268774
http://dx.doi.org/10.1038/s41467-020-19833-3

Ejemplares similares